CLASS I ONGOING Device recall · Reported 14 Feb 2024 · FDA Enforcement Report

Cardinal Health Monoject Tuberculin Syringe Luer-Lock Tip Soft Pack recalled

Cardinal Health 200 is recalling Cardinal Health Monoject Tuberculin Syringe Luer-Lock Tip Soft Pack, distributed nationwide in the US. The recall was initiated on 28 Dec 2023 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesUDI/DI 50192253034538 (Case), 20192253034537 (Box), 10192253034530 (Each), Lot Numbers: 221201, 221202, 221203, 230201, 230202, 230203, 230204, 230205, 230601

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0851-2024
FDA event ID
93676
Recalling firm
Cardinal Health 200, Waukegan, IL
Classification
Class I
Status
Ongoing
Recall initiated
28 Dec 2023
FDA classified
2 Feb 2024
Reported
14 Feb 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

28 Dec 2023Recall initiated by company
2 Feb 2024Classified by FDA+36 days
14 Feb 2024Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Cardinal Health is expanding their previous product correction actions to a product removal of all sizes of Cardinal Health brand Monoject sterile Syringe Luer-Lock (1, 3, 6, 12, 20, 35, and 60 mL) and Cardinal Health brand Monoject sterile Enteral Syringes with the ENFit connection (1, 3, 6, 12, 35, and 60 mL) due to a change in manufacturing and rebranding efforts.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Cardinal Health Monoject, 1 mL Tuberculin Syringe Luer-Lock Tip Soft Pack, REF 1180100777

Where it was distributed

Distribution US nationwide and Canada. Foreign distribution updated 9/6/2024 to only include Canada.

Nationwide

Questions about this recall

Why was it recalled?

Cardinal Health is expanding their previous product correction actions to a product removal of all sizes of Cardinal Health brand Monoject sterile Syringe Luer-Lock (1, 3, 6, 12, 20, 35, and 60 mL) and Cardinal Health brand Monoject sterile Enteral Syringes with the ENFit connection (1, 3, 6, 12, 35, and 60 mL) due to a change in manufacturing and rebranding efforts.

Which lots are affected?

UDI/DI 50192253034538 (Case), 20192253034537 (Box), 10192253034530 (Each), Lot Numbers: 221201, 221202, 221203, 230201, 230202, 230203, 230204, 230205, 230601

Where was it sold?

Distribution US nationwide and Canada. Foreign distribution updated 9/6/2024 to only include Canada.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

12 other products · FDA event 93676

This product is part of a recall event; the main page for the event is Cardinal Health Monoject Purple Enteral Syringe recalled.

More recalls from Cardinal Health 200

All 283

Other Syringes & Needles recalls

All 1,060